Status: current, Defined. Date: 31-May 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3865181000168118 | Abisart HCT 300/25 (hydrochlorothiazide 25 mg + irbesartan 300 mg) tablet, 14 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3865191000168115 | Abisart HCT 300/25 tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abisart HCT 300/25 tablet, 14 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Abisart HCT 300/25 tablet, 14 | Is a | irbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 14 | true | Inferred relationship | Some | ||
| Abisart HCT 300/25 tablet, 14 | has TPUU | Abisart HCT 300/25 tablet | true | Inferred relationship | Some | 1 | |
| Abisart HCT 300/25 tablet, 14 | has TP | Abisart HCT 300/25 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abisart HCT 300/25 tablet, 14, bottle | Is a | True | Abisart HCT 300/25 tablet, 14 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR